To the Editor

We thank Dr Gupta et al for their interest in our manuscript. We certainly agree with their comments regarding the potential limitations of our single‐center, observational analysis and have acknowledged these in the limitations section.

Precisely because of this potential for underpowered analysis, we also performed a parallel and complementary study using a large US administrative claims dataset, OptumLabs, which was published last year in JAMA.[1](#clc23157-bib-0001){ref-type="ref"} Interestingly, this larger study demonstrated that, among 8590 propensity score‐matched patients, LAA exclusion was associated with a reduced risk of stroke (1.14 vs 1.59 events per 100 person‐years; hazard ratio \[HR\], 0.73 \[95% CI, 0.56‐0.96\]; *P* = 0.03). However, since large administrative datasets have the limitation of lack of surgical details and manual/clinical event adjudication, we conducted this single center study to complement the larger study and provide more granular clinical detail. We did include information regarding the method of closure in our manuscript, although we agree with Dr Gupta that an even more granular subdivision of the closure technique would have been valuable. Even more helpful would have been data regarding the long‐term completeness of LAA exclusion from systemic circulation with serial TEE data. Unfortunately, due to the retrospective nature of the study this was rarely available.

Finally, we along with many others in the cardiology and cardiovascular surgery community eagerly await the results of the LAAOS III trial. Until data from randomized controlled trials is available, continuing the standard of care---anticoagulation based on global assessment of stroke risk---should be continued regardless of whether or not the left atrial appendage has been excluded from systemic circulation by surgical means.
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